Search Results - "Maniadakis, N"

Refine Results
  1. 1

    The economic burden of back pain in the UK by Maniadakis, Nikolaos, Gray, Alastair

    Published in Pain (Amsterdam) (2000)
    “…This paper reports the results of a ‘cost-of-illness’ study of the socio-economic costs of back pain in the UK. It estimates the direct health care cost of…”
    Get full text
    Journal Article
  2. 2

    Comprehensive taxonomy and worldwide trends in pharmaceutical policies in relation to country income status by Maniadakis, N, Kourlaba, G, Shen, J, Holtorf, A

    Published in BMC health services research (25-05-2017)
    “…Rapidly evolving socioeconomic and technological trends make it challenging to improve access, effectiveness and efficiency in the use of pharmaceuticals. This…”
    Get full text
    Journal Article
  3. 3

    A literature review to evaluate the clinical and economic value of Olmesartan for the treatment of hypertensive patients by Kourlaba, G, Gialama, F, Tsioufis, K, Maniadakis, N

    Published in International journal of cardiology (15-10-2016)
    “…Abstract The objective of the present study was to systematically review the clinical and economic outcomes of olmesartan as monotherapy or in combination with…”
    Get full text
    Journal Article
  4. 4

    The heart failure pandemic: the clinical and economic burden in Greece by Stafylas, P, Farmakis, D, Parissis, J, Kourlaba, G, Giamouzis, G, Tsarouhas, K, Maniadakis, N

    Published in International journal of cardiology (15-01-2017)
    “…Abstract Background The objective of this study was to identify the epidemiological and clinical characteristics of heart failure (HF) patients in Greece as…”
    Get full text
    Journal Article
  5. 5

    8C.06: COST-EFFECTIVENESS OF TWO SINGLE-PILL TRIPLE ANTIHYPERTENSIVE THERAPIES BASED ON THE AMBULATORY BLOOD PRESSURE MEASUREMENTS by Stafylas, P, Mavrodi, A, Kourlaba, G, Maniadakis, N

    Published in Journal of hypertension (01-06-2015)
    “…OBJECTIVE:To compare the cost-effectiveness of the two single-pill triple antihypertensive therapies available in Greece using the ambulatory blood pressure…”
    Get full text
    Journal Article
  6. 6

    Coronary artery bypass grafting with minimal versus conventional extracorporeal circulation; an economic analysis by Anastasiadis, K, Fragoulakis, V, Antonitsis, P, Maniadakis, N

    Published in International journal of cardiology (15-10-2013)
    “…Abstract Background This study aims to develop a methodological framework for the comparative economic evaluation between Minimal Extracorporeal Circulation…”
    Get full text
    Journal Article
  7. 7

    Cost of skeletal complications from bone metastases in six European countries by Pereira, J, Body, J-J, Gunther, O, Sleeboom, H, Hechmati, G, Maniadakis, N, Terpos, E, Acklin, Y P, Finek, J, von Moos, R

    Published in Journal of medical economics (02-06-2016)
    “…Objective Patients with bone metastases or lesions secondary to solid tumors or multiple myeloma often experience bone complications (skeletal-related events…”
    Get more information
    Journal Article
  8. 8

    The economic burden of coronary heart disease in the UK by Liu, J L Y, Maniadakis, N, Gray, A, Rayner, M

    Published in Heart (British Cardiac Society) (01-12-2002)
    “…Objective: To estimate the economic burden of coronary heart disease in the UK using both direct and indirect costs. Design and setting: A prevalence based…”
    Get full text
    Journal Article
  9. 9

    Cost-utility analysis of certolizumab pegol in combination with methotrexate in patients with moderate-to-severe active rheumatoid arthritis in Greece by Tzanetakos, C., Tzioufas, A., Goules, A., Kourlaba, G., Theodoratou, T., Christou, P., Maniadakis, N.

    Published in Rheumatology international (01-09-2017)
    “…We aimed to evaluate the cost-effectiveness of certolizumab pegol (CZP), a pegylated fc-free anti-TNF, as add-on therapy to methotrexate (MTX) versus…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20